Autologous Nucleus Pulposus Cells therapy (ASTEROGENE Biomedical)

N/A

Report date: 2026/04/04 20:00:24

Base Information

Drug NameAutologous Nucleus Pulposus Cells therapy (ASTEROGENE Biomedical)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Nucleus pulposus cell therapyCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsIntervertebral Disc Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesASTEROGENE Biomedical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesASTEROGENE Biomedical Co Ltd

Inactive CompaniesN/A

Active IndicationsIntervertebral Disc Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A